logo

Quick Facts

Share

British drug major AstraZeneca PLC (AZN.L, AZN) announced Monday that its COVID-19 vaccine, Vaxzevria, has been granted approval in the European Union as a third dose booster in adults. The vaccine can now be used as a third dose booster in patients previously given a primary vaccine schedule of either...

Swiss building materials company Holcim Group (HCMLY.PK, HCMLF.PK) Monday said it has acquired Louisiana, USA -based Cajun Ready Mix Concrete. The financial terms of the deal were not disclosed. Holcim said it will integrate Cajun's eight ready-mix concrete plants, 108 employees and 51 mixer trucks. The...

Creo Medical Group plc (CREO.L), a medical device company focused on surgical endoscopy, Monday announced that it has signed a long-term, multi-year collaboration agreement with Intuitive Surgical Inc. (ISRG) to optimise certain Creo products to be compatible with Intuitive's robotic technology. Intuitive...

The European Medicines Agency's or EMA Committee for Medicinal Products for Human Use or CHMP adopted a positive opinion recommending the approval of upadacitinib (RINVOQ, 45 mg [induction dose] and 15 mg and 30 mg [maintenance dose]) for the treatment of adult patients with moderately to severely active...

Alcon (ALC) said it agreed to acquire EYSUVIS (loteprednol etabonate suspension) 0.25% pharmaceutical eye drops from Kala Pharmaceuticals Inc. EYSUVIS was approved by the U.S. Food & Drug Administration in January 2021 as the first-and-only corticosteroid indicated for up to two weeks of treatment...

PrimeEnergy Resources Corporation (PNRG) Friday reported first-quarter net income of $11.1 million or $4.07 per shared, compared to net loss of $1.46 million or $0.73 per share last year. Revenues for the quarter were $26.2 million, a surge from $13.0 million last year. The company's barrel of...

Novartis (NVS) said Friday that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA has adopted a positive opinion for Cosentyx (secukinumab), used alone or in combination with methotrexate, in the juvenile idiopathic arthritis categories of enthesitis-related...

Lear Corp. (LEA) agreed to acquire I.G. Bauerhin (IGB), a privately held supplier of automotive seat heating, ventilation, active cooling, steering wheel heating, seat sensors, and electronic control modules, for 140 million euros, on a cash- and debt-free basis. The transaction is expected to close...

Biopharmaceutical company Cortexyme, Inc. (CRTX) announced Friday the completion of its acquisition of privately-held biotech company Novosteo, which targets therapeutics to treat rare skeletal diseases, bone cancer and injury. Novosteo stockholders now own approximately 15.5% of the combined company. With...

Immix Biopharma Inc. (IMMX) announced positive interim study data showing that after one cycle of treatment, ImmixBio's lead candidate IMX-110 produced 75% survival vs. 0% survival for Trabectedin in a connective tissue cancer Soft Tissue Sarcoma or STS mice study. Trabectedin is sold as YONDELIS...

Biopharmaceutical company AbbVie Inc. (ABBV) announced Friday that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor fluctuations in patients with advanced Parkinson's disease (PD). The submission...

Nissan Motor Co., Ltd. (NSANF.PK, NSANY.PK) on Friday unveiled the all-new Sakura electric minivehicle in Japan, while Mitsubishi Motors Corp. (MMTOF.PK) announced the launch of an easy-to-use, all-electric microcar eK X EV in Japan, with both offering a range of 180 kms. The Sakura EV is equipped...

The European Medicines Agency's or EMA Committee for Medicinal Products for Human Use or CHMP has issued a positive opinion for Olumiant (baricitinib) for the treatment of adults with severe alopecia areata (AA), Eli Lilly and Co. (LLY) and Incyte (INCY) said in a statement on Friday. The European...

PTC Therapeutics Inc. (PTCT) said that Upstaza received a positive opinion from the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA. Once ratified by the European Commission, Upstaza will be the first approved disease-modifying treatment for aromatic...

Match Group, Inc. (MTCH) announced Friday it has withdrawn its request for a temporary restraining order against Google, after Google made various concessions that Match Group demanded to benefit consumers. Those include guaranteeing that Match Group apps will still be allowed to offer users choice...

Follow RTT